文献速递消化道肿瘤放疗放疗物理与技术

识别在MR引导放疗中从计划自适应获益的局部晚期胰腺癌患者

Identification of patients with locally advanced pancreatic cancer benefitting from plan adaptation in MR-guided radiation therapy.
PubMed 文献 · Radiother Oncol · 2018-12-20

该研究分析36例接受MR引导放疗(40 Gy/5次)的局部晚期胰腺癌患者共180个分次的计划自适应获益情况。在线自适应后满足机构约束的计划比例由43.9%升至83.3%,GTV覆盖改善、OAR高剂量降低;自适应在约半数分次中有获益,决策树分析显示肿瘤与OAR距离≤3 mm及GTV大小是获益的主要决定因素。

要点

  • 在线自适应后满足机构约束的计划比例由43.9%升至83.3%,GTV覆盖改善且OAR的V33Gy降低。
  • 180个分次中自适应「不需要」80个(44.4%)、「有获益」95个(52.8%)、「无获益」5个(2.8%)。
  • 决策树分析显示,GTV与邻近OAR距离≤3 mm及GTV大小是每日计划自适应获益的主要决定因素。

核心结论

  • 对局部晚期胰腺癌行MR引导放疗并每日计划自适应,在约半数分次中有获益,可改善靶区覆盖并保护危及器官。
  • 计划自适应似乎主要在GTV与邻近OAR距离≤3 mm的病例中具有意义。

研究设计与样本

  • 单臂分析:36例连续局部晚期胰腺癌患者接受MR引导放疗,处方剂量40 Gy分5次。
  • 对180个分次比较非自适应计划与重新优化计划,评估GTV覆盖与OAR高剂量,并按机构目标依从性将每个分次的自适应判定为「不需要」「有获益」或「无获益」,另行决策树分析。

主要发现

  • 满足机构约束的计划比例由非自适应计划的43.9%升至在线计划自适应后的83.3%,GTV覆盖及OAR的V33Gy剂量均有显著改善。
  • 180个分次中自适应「不需要」80个(44.4%)、「有获益」95个(52.8%)、「无获益」5个(2.8%)。
  • 决策树分析识别出以肿瘤至OAR距离≤3 mm和GTV大小为依据的分组,为每日计划自适应获益的主要决定因素。

关键数值与推荐

  • 计划自适应获益判定依据:GTV覆盖与OAR高剂量,以及对机构GTV覆盖和高剂量OAR约束目标的依从性。
  • 满足机构约束的计划比例:非自适应计划43.9% vs 在线计划自适应后83.3%。
  • 分次自适应判定:不需要80/180(44.4%)、有获益95/180(52.8%)、无获益5/180(2.8%)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: MR-guided radiation therapy (MRgRT) with daily plan adaptation is a novel but time- and resource-intensive treatment for locally advanced pancreatic cancer (LAPC). We analyzed the benefit in target coverage and organ-at-risk (OAR) sparing of daily plan adaptation in 36 consecutive LAPC patients treated with MRgRT to 40 Gy in 5 fractions. MATERIALS AND METHODS: Adaptive planning was assessed for 180 fractions by comparing non-adapted plans with re-optimized plans using (a) GTV coverage and OAR high-doses, and (b) compliance with institutional objectives for GTV coverage and high-dose OAR constraints. Using these criteria, plan adaptation for each fraction was characterized as "not needed", "beneficial", or "no benefit". Decision-tree analysis was performed to identify subgroups most likely or not to benefit from routine plan adaptation. RESULTS: The percentage of plans fulfilling institutional constraints increased from 43.9% (non-adapted plans) to 83.3% after online plan adaptation, with significant improvements in GTV coverage and lower V33Gy OAR doses. Adaptive re-optimization was found to be "not needed" in 80 fractions (44.4%), "beneficial" in 95 fractions (52.8%) and of "no benefit" in 5 fractions (2.8%). Decision-tree analysis identified a grouping based on distance from tumor to OAR of ≤3 mm and GTV size, respectively, to be the major determinants for the benefit of daily plan adaptation. CONCLUSION: MRgRT with daily plan adaptation for LAPC was of benefit in approximately half of fractions, improving target coverage and OAR sparing. Plan adaptation appeared to be relevant mainly in cases where the GTV to adjacent OAR distance was ≤3 mm.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Bohoudi O, Bruynzeel AME, Meijerink MR, et al. Identification of patients with locally advanced pancreatic cancer benefitting from plan adaptation in MR-guided radiation therapy. Radiother Oncol. 2018. PMID: 30825964. doi:10.1016/j.radonc.2018.11.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。